Effect of Prostaglandin E1 on Peritoneal Membrane Transport in CAPD-Treated Diabetic Patients

Flessner M. Changes in the peritoneal interstitium and their effect on peritoneal transport. Perit Dial Int 1999; 19(Suppl 2): S77–82.

Campbell W. Lipid derived autacoids: eicosanoids and platelet-activating factor. In: Gilman A. , Rall T. , Nies A. , Taylor P. , eds. The Pharmacological Basis of Therapeutics. International Edition. 9th ed. New York: Pergamon Press; 1992; Vol I: 600–17.

Rubin D. , Laposata M. Regulation of agonist-induced prostaglandin E1 versus prostaglandin E2 production. A mass analysis. J Biol Chem 1991; 266: 23618–23.

Peng H. , Cheung A. , Reimer C. , Kamerath C. , Leypoldt J. Effect of indomethacin on peritoneal protein loss in a rabbit model of peritonitis. Kidney Int 2001; 59: 44–51.

Douma C.E. , de Waart D.R. , Zemel D. , Struijk D. , Krediet R.T. Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD. Nephrol Dial Transplant 2001; 16: 803–8.

Zemel D. , Michiel G. , Betjes C. , Struijk D. , Krediet T. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD. Perit Dial Int 1995; 15: 134–41.

Zemel D. , Krediet R. Cytokine patterns in the effluent of continuous ambulatory peritoneal dialysis: relationship to peritoneal permeability. Blood Purif 1996; 14: 198–216.

Twardowski Z. , Nolph K. , Khanna R. , Prowant B. , Ryan L. , Moore H. Peritoneal equilibration test. Perit Dial Bull 1987; 7: 138–47.

Waniewski J. , Heimbürger O. , Werynski A. , Lindholm B. Aqueous solute concentration and evaluation of mass transfer coefficients in peritoneal dialysis. Blood Purif 1991; 9: 129–41.

Steinhauer H. , Schollmeyer P. Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis. Kidney Int 1986; 29: 584–90.

Douma C. , de Waart D. , Struijk D. , Krediet R. The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD. Kidney Int 1997; 51: 1885–92.

Miller F.N. , Nolph K.D. , Harris P.D. , Rubin J. , Wiegman D.L. , Joshua I. Microvascular and clinical effects of altered peritoneal dialysis solutions. Kidney Int 1979; 15: 630–9.

Rosengren B. , Rippe A. , Rippe C. , Venturoli D. , Sward K. , Rippe B. Transvascular protein transport in mice lacking endothelial caveolae. Am J Physiol Heart Circ Physiol 2006; 291: H1371–H1377.

Paniagua R. , Ventura J. , Rodríguez E. , Sil J. , Galindo T. , Hurtado M.E. Impact of fill volume on peritoneal clearances and cytokine appearance in peritoneal dialysis. Perit Dial Int 2004; 24: 156–62.